ArticleCancer research2015

The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.

Bhavatarini Vangamudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.